Aurion Biotech

Aurion Biotech is a clinical-stage biotech company focused on developing advanced therapies to cure blindness. Their mission is to restore vision to millions of patients suffering from corneal endothelial diseases. The company has developed a novel cell therapy, Vyznova®, which uses cultured corneal endothelial cells to regenerate healthy cells in the eye. This treatment has already received regulatory approval in Japan for the treatment of bullous keratopathy, a sight-threatening condition. Aurion Biotech is also preparing for clinical trials in the US and Canada.

Aurion Biotech is backed by leading investors including Deerfield, Alcon, Petrichor, Flying L Partners, Falcon Vision / KKR, and Visionary Ventures. The company's team boasts deep experience in ophthalmology, cell and gene therapies, clinical trials, regulatory affairs, manufacturing, and commercialization. Their innovative approach to cell therapy holds the potential to revolutionize the treatment of corneal endothelial diseases and restore sight to millions of patients worldwide.

Aurion Biotech embraces a flexible and fast-paced work environment, encouraging open communication and offering flexible work schedules to empower employees to do their best work. They believe in a culture of change and value their employees' contributions, providing opportunities for growth and skill development through online courses and team teach-ins.

Aurion Biotech offers a robust benefits package that includes full health insurance for employees and their families, 401(k) matching, employee assistance programs (EAP), flexible spending accounts (FSA), and generous paid time off (PTO). Additionally, they offer competitive equity grants, salaries, and bonuses. Employees are also given flexible work schedules and opportunities to grow professionally through online courses and team teach-ins. The company also provides perks like subsidized commuter passes, catered lunches, team events, and community projects.

Aurion Biotech is a clinical-stage biotech company committed to restoring vision to millions of patients suffering from blindness. They develop a platform of innovative, accessible, and effective advanced therapies, with their first candidate being a patented cell therapy treatment for corneal endothelial disease. The company aims to cure leading forms of blindness and transform the lives of patients worldwide by developing a platform of advanced therapies.

Aurion Biotech fosters a culture of grit, stewardship, and transformation. They encourage their employees to be persistent, resilient, and committed to achieving the impossible. They value teamwork, collaboration, and open communication, believing that "heads together make better decisions." They also emphasize the importance of giving back to the community and making a positive impact on the world. Aurion Biotech values diversity of thought and expertise, and encourages their employees to take risks, learn from their mistakes, and embrace new challenges.

Aurion Biotech values a diverse and inclusive workforce, believing that a variety of backgrounds, locations, and expertise can be leveraged to achieve a common purpose. They embrace challenges, successes, and failures, encouraging curiosity, risk-taking, and collaboration in their work environment. Their commitment to diversity is evident in their company values, which include grit, stewardship, and transformation, and in their efforts to create a healthy, fun, and rewarding work environment for all employees.